Skip to main content
Erschienen in: Comparative Clinical Pathology 3/2020

24.04.2020 | Original Article

Effects of pirfenidone, vitamin E, and pirfenidone–vitamin E combination in paraquat-induced pulmonary fibrosis

verfasst von: Rokhsana Rasooli, Younes Kamali, Ali Mandegary

Erschienen in: Comparative Clinical Pathology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Paraquat-induced pulmonary fibrosis is a progressive and fatal interstitial lung disease, a condition for that, there is no effective treatment and its prognosis is appalling. Since multiple coactivated pathways are involved, targeting these pathways using combination regimens is plausible for successful therapy. So, the aim of the present study was to evaluate the therapeutic efficacy of pirfenidone–vitamin E combination therapy in (paraquat) PQ-induced lung fibrosis model. After the development of PQ-induced lung fibrosis, pirfenidone, vitamin E, pirfenidone plus vitamin E, and water (as a vehicle) were orally administered for 14 consecutive days (From day 14 to day 28). The comparison of efficacies was performed by evaluating histopathology changes, hydroxyproline content, and oxidative stress. Either pirfenidone or vitamin E solely could recover the pathological changes of paraquat, decreased lipid peroxidation, and restored the antioxidant enzymes towards normal values. Hydroxyproline content was significantly reduced by both pirfenidone and vitamin E administration. Concurrent treatment with pirfenidone and vitamin E intensified all of these therapeutics effects indicating more potent antifibrotic and anti-inflammatory impacts. Therefore, pirfenidone plus vitamin E offers potential as a combination therapy for the treatment of paraquat-induced pulmonary fibrosis.
Literatur
Zurück zum Zitat Ashcroft T, Simpson JM, Timbrell V (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467–470CrossRef Ashcroft T, Simpson JM, Timbrell V (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467–470CrossRef
Zurück zum Zitat Bese N et al (2007) Vitamin E protects against the development of radiation-induced pulmonary fibrosis in rats. Clin Oncol 19:260–264CrossRef Bese N et al (2007) Vitamin E protects against the development of radiation-induced pulmonary fibrosis in rats. Clin Oncol 19:260–264CrossRef
Zurück zum Zitat Beyer WF, Fridovich I (1987) Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem 161:559–566CrossRef Beyer WF, Fridovich I (1987) Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem 161:559–566CrossRef
Zurück zum Zitat Bus JS, Gibson JE (1984) Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55:37CrossRef Bus JS, Gibson JE (1984) Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55:37CrossRef
Zurück zum Zitat Card JW, Racz WJ, Brien JF, Massey TE (2003) Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-β1 gene expression but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther 304:277–283CrossRef Card JW, Racz WJ, Brien JF, Massey TE (2003) Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-β1 gene expression but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther 304:277–283CrossRef
Zurück zum Zitat Day BJ (2008) Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10:355–370CrossRef Day BJ (2008) Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10:355–370CrossRef
Zurück zum Zitat Deger Y, Yur F, Ertekin A, Mert N, Dede S, Mert H (2007) Protective effect of α-tocopherol on oxidative stress in experimental pulmonary fibrosis in rats. Cell Biochem Funct 25:633–637CrossRef Deger Y, Yur F, Ertekin A, Mert N, Dede S, Mert H (2007) Protective effect of α-tocopherol on oxidative stress in experimental pulmonary fibrosis in rats. Cell Biochem Funct 25:633–637CrossRef
Zurück zum Zitat Devaraj S, Jialal I (2005) α-Tocopherol decreases tumor necrosis factor-α mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med 38:1212–1220CrossRef Devaraj S, Jialal I (2005) α-Tocopherol decreases tumor necrosis factor-α mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med 38:1212–1220CrossRef
Zurück zum Zitat Dou T et al. (2015) Nrf2/ARE pathway involved in oxidative stress induced by paraquat in human neural progenitor cells. Oxidative medicine and cellular longevity 2016 Dou T et al. (2015) Nrf2/ARE pathway involved in oxidative stress induced by paraquat in human neural progenitor cells. Oxidative medicine and cellular longevity 2016
Zurück zum Zitat Elenga N et al (2018) Clinical features and prognosis of paraquat poisoning in French Guiana: a review of 62 cases. Medicine 97 Elenga N et al (2018) Clinical features and prognosis of paraquat poisoning in French Guiana: a review of 62 cases. Medicine 97
Zurück zum Zitat Fois AG et al (2018a) Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir Res 19:51CrossRef Fois AG et al (2018a) Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir Res 19:51CrossRef
Zurück zum Zitat Fois AG et al (2018b) Antioxidant activity mediates pirfenidone antifibrotic effects in human pulmonary vascular smooth muscle cells exposed to sera of idiopathic pulmonary fibrosis patients. Oxidative Med Cell Longev:2018 Fois AG et al (2018b) Antioxidant activity mediates pirfenidone antifibrotic effects in human pulmonary vascular smooth muscle cells exposed to sera of idiopathic pulmonary fibrosis patients. Oxidative Med Cell Longev:2018
Zurück zum Zitat Futamura Y (1996) Toxicity of amiodarone on mouse pulmonary endothelial cells cultured with or without alveolar macrophages. J Toxicol Sci 21:253–267CrossRef Futamura Y (1996) Toxicity of amiodarone on mouse pulmonary endothelial cells cultured with or without alveolar macrophages. J Toxicol Sci 21:253–267CrossRef
Zurück zum Zitat Gao F, Kinnula VL, Myllärniemi M, Oury TD (2008) Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 10:343–354CrossRef Gao F, Kinnula VL, Myllärniemi M, Oury TD (2008) Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 10:343–354CrossRef
Zurück zum Zitat Hemmati A, Nazari Z, Ranjbari N, Torfi A (2008) Comparison of the preventive effect of vitamin C and E on hexavalent chromium induced pulmonary fibrosis in rat. Inflammopharmacology 16:195–197CrossRef Hemmati A, Nazari Z, Ranjbari N, Torfi A (2008) Comparison of the preventive effect of vitamin C and E on hexavalent chromium induced pulmonary fibrosis in rat. Inflammopharmacology 16:195–197CrossRef
Zurück zum Zitat Iyer SN, Hyde DM, Giri SN (2000) Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation. Inflammation 24:477–491CrossRef Iyer SN, Hyde DM, Giri SN (2000) Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation. Inflammation 24:477–491CrossRef
Zurück zum Zitat Kachel D, Moyer T, Martin W (1990) Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. J Pharmacol Exp Ther 254:1107–1112PubMed Kachel D, Moyer T, Martin W (1990) Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. J Pharmacol Exp Ther 254:1107–1112PubMed
Zurück zum Zitat Kalantar M, Khodayar MJ, Kalantari H, Khorsandi L, Hemmati AA (2018) Therapeutic effect of gallic acid against paraquat-induced lung injury in rat. Jundishapur J Nat Pharm Prod 13:13 Kalantar M, Khodayar MJ, Kalantari H, Khorsandi L, Hemmati AA (2018) Therapeutic effect of gallic acid against paraquat-induced lung injury in rat. Jundishapur J Nat Pharm Prod 13:13
Zurück zum Zitat Kandhare AD, Mukherjee A, Ghosh P, Bodhankar SL (2016) Efficacy of antioxidant in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. EXCLI J 15:636PubMedPubMedCentral Kandhare AD, Mukherjee A, Ghosh P, Bodhankar SL (2016) Efficacy of antioxidant in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. EXCLI J 15:636PubMedPubMedCentral
Zurück zum Zitat Kar S, Biswas S, Banerjee ER (2016) Evaluating the ameliorative potential of plant flavonoids and their nanocomposites in bleomycin induced idiopathic pulmonary fibrosis. Biomed Res Therapy 3:707–722CrossRef Kar S, Biswas S, Banerjee ER (2016) Evaluating the ameliorative potential of plant flavonoids and their nanocomposites in bleomycin induced idiopathic pulmonary fibrosis. Biomed Res Therapy 3:707–722CrossRef
Zurück zum Zitat Li T, Yang X, Xin S, Cao Y, Wang N (2017) Paraquat poisoning induced pulmonary epithelial mesenchymal transition through Notch1 pathway. Sci Rep 7:924CrossRef Li T, Yang X, Xin S, Cao Y, Wang N (2017) Paraquat poisoning induced pulmonary epithelial mesenchymal transition through Notch1 pathway. Sci Rep 7:924CrossRef
Zurück zum Zitat Liu M-W et al (2016) Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression. BMC Complement Altern Med 16:1 Liu M-W et al (2016) Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression. BMC Complement Altern Med 16:1
Zurück zum Zitat Oku H, Nakazato H, Horikawa T, Tsuruta Y, Suzuki R (2002) Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10 and protects mice from endotoxic shock. Eur J Pharmacol 446:167–176CrossRef Oku H, Nakazato H, Horikawa T, Tsuruta Y, Suzuki R (2002) Pirfenidone suppresses tumor necrosis factor-α, enhances interleukin-10 and protects mice from endotoxic shock. Eur J Pharmacol 446:167–176CrossRef
Zurück zum Zitat Oku H et al (2008) Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 590:400–408CrossRef Oku H et al (2008) Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 590:400–408CrossRef
Zurück zum Zitat Pourgholamhossein F et al (2018) Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression. Food Chem Toxicol 112:39–46CrossRef Pourgholamhossein F et al (2018) Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression. Food Chem Toxicol 112:39–46CrossRef
Zurück zum Zitat Reddy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229CrossRef Reddy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229CrossRef
Zurück zum Zitat Ruch RJ, Bandyopadhyay S, Somani P, Klaunig JE (1991) Evaluation of amiodarone free radical toxicity in rat hepatocytes. Toxicol Lett 56:117–126CrossRef Ruch RJ, Bandyopadhyay S, Somani P, Klaunig JE (1991) Evaluation of amiodarone free radical toxicity in rat hepatocytes. Toxicol Lett 56:117–126CrossRef
Zurück zum Zitat Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J (2008) Potent antioxidant role of pirfenidone in experimental cirrhosis. Eur J Pharmacol 595:69–77CrossRef Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J (2008) Potent antioxidant role of pirfenidone in experimental cirrhosis. Eur J Pharmacol 595:69–77CrossRef
Zurück zum Zitat Schaefer C, Ruhrmund D, Pan L, Seiwert S, Kossen K (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20:85–97CrossRef Schaefer C, Ruhrmund D, Pan L, Seiwert S, Kossen K (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20:85–97CrossRef
Zurück zum Zitat Seifirad S, Keshavarz A, Taslimi S, Aran S, Abbasi H, Ghaffari A (2012) Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats. Clin Toxicol 50:754–758CrossRef Seifirad S, Keshavarz A, Taslimi S, Aran S, Abbasi H, Ghaffari A (2012) Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats. Clin Toxicol 50:754–758CrossRef
Zurück zum Zitat Selvaggio AS, Noble PW (2016) Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis. Annu Rev Med 67:487–495CrossRef Selvaggio AS, Noble PW (2016) Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis. Annu Rev Med 67:487–495CrossRef
Zurück zum Zitat Veith C, Boots AW, Idris M, van Schooten F-J, van der Vliet A (2019) Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross-talk between NADPH oxidase enzymes and mitochondria. Antioxid Redox Signal Veith C, Boots AW, Idris M, van Schooten F-J, van der Vliet A (2019) Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross-talk between NADPH oxidase enzymes and mitochondria. Antioxid Redox Signal
Zurück zum Zitat Verma R, Kushwah L, Gohel D, Patel M, Marvania T, Balakrishnan S (2013) Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in wistar rats. Pulm Med:2013 Verma R, Kushwah L, Gohel D, Patel M, Marvania T, Balakrishnan S (2013) Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in wistar rats. Pulm Med:2013
Metadaten
Titel
Effects of pirfenidone, vitamin E, and pirfenidone–vitamin E combination in paraquat-induced pulmonary fibrosis
verfasst von
Rokhsana Rasooli
Younes Kamali
Ali Mandegary
Publikationsdatum
24.04.2020
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 3/2020
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-020-03104-0

Weitere Artikel der Ausgabe 3/2020

Comparative Clinical Pathology 3/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie